Edwards Wants Nerve-Tech Patent Nixed In Medtronic IP Row

Law360, New York (July 15, 2013, 5:16 PM EDT) -- Medical device maker Edwards Lifesciences Corp. on Friday challenged the validity of a patent covering nerve stimulation technology that its longtime adversary Medtronic Inc. is accusing Edwards' devices of infringing.

In a summary judgment motion filed in California federal court, the Irvine, Calif.-based firm argued that U.S. Patent No. 8,036,741, entitled Method and System for Nerve Stimulation and Cardiac Sensing Prior To and During a Medical Procedure, is invalid because it does not satisfy U.S. Code requirements that the patent specification should have a clear written...
To view the full article, register now.